Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Clinical and Translational Science
|
April 2, 2024
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers
Tianxing Liu, Kensei Hashizume, Eva Krieg, et al.
Therapeutic Advances in Medical Oncology
|
April 29, 2025
Efficacy and safety of radiotherapy to delay second-line systemic therapy in patients with oligoprogressive hepatocellular carcinoma: study protocol of a multicentre, single-arm, phase II trial
Haohua Wang, Xiang Zhang, Kunli Zhu, et al.
Phytochemistry
|
January 21, 2017
Isolation, characterization and antimicrobial activities of polyacetylene glycosides from Coreopsis tinctoria Nutt
Jia Guo, Ao Wang, Ke Yang, et al.
Cancer Medicine
|
October 19, 2021
Interleukin-33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer
Xujun Zhang, Kefan Bi, Xiaoxuan Tu, et al.
Journal of Migration and Health
|
April 3, 2023
Mental health conditions of Chinese international students and associated predictors amidst the pandemic
Linke Yu, Ying Cao, Yiran Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2024
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
Zhilang Li, Lisha Ma, Zhaoya Gao, et al.
Cell
|
April 18, 2026
p53 safeguards chemical reprogramming of human somatic cells toward pluripotency
Lin Cheng, Yanglu Wang, Zhihan Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
September 17, 2025
A Serum-Stable Antimicrobial Peptide-Based Delivery Platform for Selective Treatment of Nontargetable and Chemoresistant Tumors
Tianxing Liu, Lingyu Ke, Ruize Sun, et al.
Cell Discovery
|
December 23, 2025
Robust generation of clinically applicable human pluripotent stem cells from peripheral blood by chemical reprogramming
Xiaodi Fu, Fangqi Peng, Ruyi Cai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 17, 2025
Maintaining First-Line Therapy Plus Radiation Therapy May Prolong Progression-Free Survival and Delay Second-Line Therapy for Oligoprogressive Hepatocellular Carcinoma
Boyu Leng, Haohua Wang, Yunfan Ge, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Clinical and Translational Science
|
April 2, 2024
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers
Tianxing Liu, Kensei Hashizume, Eva Krieg, et al.
Therapeutic Advances in Medical Oncology
|
April 29, 2025
Efficacy and safety of radiotherapy to delay second-line systemic therapy in patients with oligoprogressive hepatocellular carcinoma: study protocol of a multicentre, single-arm, phase II trial
Haohua Wang, Xiang Zhang, Kunli Zhu, et al.
Phytochemistry
|
January 21, 2017
Isolation, characterization and antimicrobial activities of polyacetylene glycosides from Coreopsis tinctoria Nutt
Jia Guo, Ao Wang, Ke Yang, et al.
Cancer Medicine
|
October 19, 2021
Interleukin-33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer
Xujun Zhang, Kefan Bi, Xiaoxuan Tu, et al.
Journal of Migration and Health
|
April 3, 2023
Mental health conditions of Chinese international students and associated predictors amidst the pandemic
Linke Yu, Ying Cao, Yiran Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2024
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
Zhilang Li, Lisha Ma, Zhaoya Gao, et al.
Cell
|
April 18, 2026
p53 safeguards chemical reprogramming of human somatic cells toward pluripotency
Lin Cheng, Yanglu Wang, Zhihan Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
September 17, 2025
A Serum-Stable Antimicrobial Peptide-Based Delivery Platform for Selective Treatment of Nontargetable and Chemoresistant Tumors
Tianxing Liu, Lingyu Ke, Ruize Sun, et al.
Cell Discovery
|
December 23, 2025
Robust generation of clinically applicable human pluripotent stem cells from peripheral blood by chemical reprogramming
Xiaodi Fu, Fangqi Peng, Ruyi Cai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 17, 2025
Maintaining First-Line Therapy Plus Radiation Therapy May Prolong Progression-Free Survival and Delay Second-Line Therapy for Oligoprogressive Hepatocellular Carcinoma
Boyu Leng, Haohua Wang, Yunfan Ge, et al.
Page
of 5